期刊文献+

6种肿瘤标志物联合检测在肺癌诊断中的价值评价 被引量:4

下载PDF
导出
摘要 目的:探讨6种肿瘤标志物联合检测在肺癌诊断中的诊断价值。方法:选取我院自2010年3月-2012年3月收治的45例肺癌患者作为观察组,选取同期我院正常体检的45例健康体检者作为参考组,对两组患者分别进行6种肿瘤标志物的测定,比较所得肿瘤标志物检测结果,观察肺癌患者肿瘤标志物的特异性与敏感度。结果:观察组患者的CA125、TSGF、CA72-4、CA125、CEA、CA15-3明显高于参考组体检者,有统计学意义(P<0.05)。肺癌患者的6种肿瘤标志物特异度及敏感度均比较高。结论:6种肿瘤标志物的联合检测在肺癌诊断中能够对疾病进行准确诊断,为患者治疗提供准确依据,值得推广。
作者 李勇
出处 《医学理论与实践》 2013年第19期2623-2624,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献3

二级参考文献21

  • 1Xiao-Ting Jiang, Hou-Quan Tao and Shou-Chun Zou Clinical Medical Laboratory and Depart-ment of Surgery , Zhejiang Provincial People’ sHospital, Hangzhou 310014 , China.Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer[J].Hepatobiliary & Pancreatic Diseases International,2004,3(3):464-468. 被引量:35
  • 2陶华林,李红霞.肿瘤标志物的研究及临床应用进展[J].国外医学(临床生物化学与检验学分册),2005,26(1):54-56. 被引量:24
  • 3Zhang YH, Li Y, Chen C, et al. Careinoembryonic antigen level is related to tumor invasion into the serosa of the stomach:study on 166 cases and suggestion for new therapy [ J ]. Hepatogastroenterology, 2009, 56 ( 96 ) : 1750-1754.
  • 4Sheng X, Du X, Zhang X, et al. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix:comparison with serum SCCA, CYFRA21 - 1, and CEA levels [ J ]. Croat Med J, 2009,50(5 ) :455-464.
  • 5Molina R, Auge JM, Escudero JM, et al. Evaluation of tumor markers ( HER - 2/neu oncoprotein, CEA, and CA 15.3 )in patients with locoregional breast cancer: prognostic value [ M ]. Tumour Biol ,2010 :2.
  • 6Nisman B, Biran H, Ramu N, et al. The diagnostic and prognostic value of ProGRP in lung cancer[ J]. Anticancer Res, 2009,29 ( 11 ) : 4827-4852.
  • 7Han M,Liu Q,Yu J,et al. Detection and significance of serum protein markers of small - cell lung cancer [ J ]. J Clin Lab Anal,2008,22(2) :131-137.
  • 8Yu B, Xu PZ, Wang QW, et al. Clinical value of tumour specific growth factor (TSGF) and carbohydrate antigen - 125 ( CA - 125 ) in carcinoma of the endometrium [ J]. J Int Med Res ,2009 ,37 (3) :878-883.
  • 9Tyczynski JE,Bray F,Parkin DM.Lung cancer in Europe in 2000:epidemiology,prevention,and early detection[J].Lancet Oneol,2003,4(1):45.
  • 10von Eggeling F,Davies H,Lomas L,et al.Tissue-specific microdissection coupled with Protein Chip array technologies:applications in caner research[J].Biotechniques,2000,29(5):1066.

共引文献23

同被引文献60

  • 1姜晓明,陈爽,杜晓艳,鞠晓红.5种血清肿瘤标志物检测在肺癌诊断中的临床价值[J].吉林医药学院学报,2013,34(2):81-84. 被引量:28
  • 2刘卫红,李志,王鹏,刘会娟,闫平平,王凯娟,代丽萍,张建营.肿瘤相关抗原抗体联合检测在肺癌早期诊断中的价值评价[J].中国卫生检验杂志,2006,16(12):1412-1414. 被引量:11
  • 3邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:151
  • 4罗杰,冷卫东.系统评价/Meta分析理论与实践[M].北京:军事医学科学出版社,2013.
  • 5陈文彬,潘祥林.诊断学[M].北京:人民卫生出版社,2011:336-352.
  • 6戴随.肿瘤标志物联合检测在肺癌诊断及预后的价值[D].天津:天津医科大学,2009.
  • 7Kagohashi K, Satoh H, Kurishima K, et al. Squamous cell carcinoma antigen in lung cancer and non-malig- nant respiratory diseases [J]. Lung, 2008, 186 ( 5 ) : 323-326.
  • 8Oremex GM,Sauer Eppel H, Bruzdziak TH. Value of tumor and inflammatory markers in lung cancer[J]. Anticancer Research,2007,27(4A) : 1911-1915.
  • 9Cho WC. Potentially useful biomarkers for the diag- nosis,treatment and prognosis of lung cancer[J]. Bi omed Pharmacother, 2007,61 (9) : 515-519.
  • 10Hu B,Tian XH,Sun J,et al. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinomata meta-analy- sis[J]. Int J Mol Sci,2013,14(12) :23559-23580.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部